Myeloid progenitor inhibitory factor (MPIF)-2 is a beta -chemokine with sel
ect and potent activities on eosinophils and myeloid progenitors. In the be
ta -chemokine family, biological activity is modulated by differential proc
essing of the amino-terminus, Here, for MPIF-2, we describe the biological
activities of NH2-terminal deletion mutants and compare regions necessary f
or eosinophil and myeloid progenitor activities. Five MPIF-2 proteins with
deletions at the amino-terminus were produced in Escherichia coli and assay
ed for calcium mobilization, chemotaxis and receptor binding activities on
eosinophils, and for their ability to inhibit colony formation of human mye
loid bone marrow progenitors. For eosinophils, deletion of the first two am
ino acids did not markedly alter activity, while subsequent truncations res
ult in a complete loss of activity. One of the MPIF-2 mutants, MPIF-2 (P30-
R99) was converted from an agonist to an antagonist of eotaxin, MPIF-2 and
MCP-4 functional responses in eosinophil calcium flux and chemotaxis assays
. Surprisingly, while displaying a complete loss of agonist activity toward
eosinophils, MPIF-2 (P30-R99) retains ability to inhibit human bone marrow
myeloid progenitor cell colony formation. In addition, processing at the a
mino terminus of MPIF-2 in vivo, may result in a chemokine with altered bio
logical activities. (C) 2001 Academic Press.